041830.KQ KOE
InBody Co.,Ltd
1W: -2.1%
1M: -14.7%
3M: -16.0%
YTD: +47.4%
1Y: +82.8%
3Y: +85.1%
5Y: +82.4%
₩52,100.00 ($38.81)
-1300.00 (-2.43%)
Weekly Expected Move ±4.5%
₩47431
₩49766
₩52100
₩54434
₩56769
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩695.1B ($517.8M)
52W Range26200-73500
Volume90,468
Avg Volume111,989
Beta0.62
Dividend₩600.00
Analyst Ratings
No analyst coverage
Company Info
CEOKi-Chul Cha
Employees266
SectorHealthcare
IndustryMedical - Specialties
IPO Date2000-12-15
Websiteinbody.com/global
InBody Building
Seoul, SL 06106
KR
Seoul, SL 06106
KR
82 2 501 3939
About InBody Co.,Ltd
InBody Co.,Ltd is a global provider of advanced body composition analysis solutions. The company offers an extensive product line, including body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, along with specialized devices like the InBody Dial and various bands. These technologies are widely employed across diverse applications, such as medical specialties like nephrology, liver disease, and diabetes, as well as in nutrition and rehabilitation programs. Originally established in 1996 and headquartered in Seoul, South Korea, the company was formerly known as Biospace Co., Ltd.
Latest News
No recent news
Recent Insider Trades
No insider trades found